These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25428793)

  • 1. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.
    Dujardin S; Colin M; Buée L
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):59-80. PubMed ID: 25428793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
    Paquet D; Schmid B; Haass C
    Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From tau phosphorylation to tau aggregation: what about neuronal death?
    Buée L; Troquier L; Burnouf S; Belarbi K; Van der Jeugd A; Ahmed T; Fernandez-Gomez F; Caillierez R; Grosjean ME; Begard S; Barbot B; Demeyer D; Obriot H; Brion I; Buée-Scherrer V; Maurage CA; Balschun D; D'hooge R; Hamdane M; Blum D; Sergeant N
    Biochem Soc Trans; 2010 Aug; 38(4):967-72. PubMed ID: 20658986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration.
    Ding Y; Lei L; Lai C; Tang Z
    J Alzheimers Dis; 2019; 69(2):339-353. PubMed ID: 31006683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in experimental modeling of the assembly of tau filaments.
    Ko LW; DeTure M; Sahara N; Chihab R; Vega IE; Yen SH
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):125-39. PubMed ID: 15615632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited review: Prion-like transmission and spreading of tau pathology.
    Clavaguera F; Hench J; Goedert M; Tolnay M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):47-58. PubMed ID: 25399729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
    Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML
    Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.
    Fuster-Matanzo A; Hernández F; Ávila J
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further understanding of tau phosphorylation: implications for therapy.
    Medina M; Avila J
    Expert Rev Neurother; 2015 Jan; 15(1):115-22. PubMed ID: 25555397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two days of tau: a meeting focused on its biology and pathology.
    Skoulakis EM; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):953-4. PubMed ID: 20658983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited review: Drug development for tauopathies.
    Grüninger F
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):81-96. PubMed ID: 25354646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
    Clavaguera F; Grueninger F; Tolnay M
    Neuropharmacology; 2014 Jan; 76 Pt A():9-15. PubMed ID: 24050961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
    Cente M; Filipcik P; Pevalova M; Novak M
    Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tau protein in both physiological and pathological conditions.
    Avila J; Lucas JJ; Perez M; Hernandez F
    Physiol Rev; 2004 Apr; 84(2):361-84. PubMed ID: 15044677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
    Alavi Naini SM; Soussi-Yanicostas N
    Oxid Med Cell Longev; 2015; 2015():151979. PubMed ID: 26576216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.
    Ubhi KK; Shaibah H; Newman TA; Shepherd D; Mudher A
    Invert Neurosci; 2007 Sep; 7(3):165-71. PubMed ID: 17636367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zebrafish Models to Study New Pathways in Tauopathies.
    Barbereau C; Cubedo N; Maurice T; Rossel M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.